Michelle Smolenaars Hunter

Michelle Smolenaars Hunter is a spokesperson for GSK, the pharmaceutical company developing gepotidacin, a promising new antibiotic for treating gonorrhea. She has announced plans for a U.S. regulatory submission for gepotidacin's use against uncomplicated gonorrhea, reflecting the company's commitment to addressing the urgent need for effective treatments amid rising antibiotic resistance.